Pharma Mirror

JANUARY 2, 2024

The popularity of at-home DNA testing is soaring in popularity and uses. When someone seeks information about paternity or genetic diseases without visiting a doctor’s chamber or laboratory, the best alternative is the at-home DNA test kit. The question which concerns everyone is, ‘are home DNA test kits accurate?’.

DNA 130

DNA Genetic Disease Genetics 130

Bio Pharma Dive

JULY 1, 2024

Ensure the safety of gene therapies with accurate HEK293 DNA measurement using Vericheck ddPCR kits.

DNA 147

DNA Gene Therapy Gene 147

Pharma Times

OCTOBER 4, 2022

University of Lincoln and the University of Sheffield are researching how DNA could be repaired

DNA 158

DNA Research 158

Bio Pharma Dive

MARCH 23, 2021

A disappointing recommendation from outside data reviewers raises doubts about the DNA-targeting drug's benefits and puts pressure on Roche's partner, Ionis Pharmaceuticals.

DNA 347

DNA Drugs 347

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2023

The Drug Controller General of India (DCGI) has added in-vitro diagnostic (IVD) medical devices including those for diagnosis of Covid-19, ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) extraction kits, among others into the Class C risk category under the Medical Devices Rules (MDR), 2017.

RNA 189

RNA DNA In-Vitro Drugs 189

Bio Pharma Dive

MAY 13, 2021

With $82 million in hand, Flare Therapeutics is looking to create precision cancer drugs by going after a type of protein called transcription factors.

DNA 252

DNA Regulation Protein Drugs 252

Bio Pharma Dive

OCTOBER 19, 2020

The trial would be the first test of a systemically administered gene editing treatment that uses the Nobel Prize-winning technology to alter DNA.

Gene Editing 328

Gene Editing DNA Gene Drugs 328

Pharma Times

NOVEMBER 29, 2022

Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA

DNA 134

DNA Vaccine Vaccination 134

Bio Pharma Dive

JULY 26, 2022

Three startups have recently emerged with plans to edit the epigenome rather than DNA directly. Here’s why that matters and what they aim to do.

DNA 331

DNA 331

Bio Pharma Dive

DECEMBER 12, 2023

Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.

Genome 334

Genome Genomics DNA Genetics 334

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: DNA polymerase compositions. The majority of DNA replication is performed by Pol δ and Pol ε.

DNA 130

DNA Antibody Vaccine Vaccination 130

Bio Pharma Dive

NOVEMBER 17, 2021

Chroma Medicine's launch is the latest step in a decadeslong quest by drugmakers to capitalize on research into epigenetics, a way of controlling gene expression without altering DNA.

Gene Expression 325

Gene Expression DNA Gene Medicine 325

Bio Pharma Dive

MARCH 23, 2022

The deal, announced alongside a $175 million round, makes biotech entrepreneur Greg Verdine's startup the most well-funded among an emerging group of companies searching for drugs in fungal DNA.

DNA 325

DNA Drugs 325

Pharmaceutical Technology

SEPTEMBER 23, 2024

s groundbreaking patent for synthesizing specific DNA sequences. Discover Telesis Bio Inc.'s Learn how their innovative method enhances genetic engineering and biotechnology.

DNA 130

DNA Genetic Engineering Engineer Genetics 130

Pharma Times

MAY 10, 2023

Transfer marks start of vital development stage as company expands its range of synthesized DNA

DNA 126

DNA Development 126

Pharmaceutical Technology

DECEMBER 7, 2023

Synplogen and Ginkgo Bioworks have signed an MOU to expedite DNA manufacturing and gene therapy platform services in Japan.

DNA 130

DNA Manufacturing Gene Therapy Gene 130

pharmaphorum

JULY 20, 2022

It has suspected for many years that some diseases may be linked to non-coding or ‘junk’ DNA, but the mechanism behind the pathology hasn’t been worked out. Junk DNA is a term used to describe the 97% of the genetic sequence in human cells found between the 3% coding for our 20,000 genes, once thought to be inert.

DNA 116

DNA Scientist Genomics Genome 116

Pharmaceutical Technology

APRIL 22, 2024

Discover how PMV Pharmaceuticals Inc's patented compounds restore DNA binding affinity of p53 mutants, aiding in tumor suppression and reducing cancer progression. Explore the specific formula and structural features outlined in the granted patent (Publication Number: US11926632B2).

DNA 130

DNA 130

BioPharma Reporter

AUGUST 2, 2021

With Scancell taking its DNA-based COVID-19 vaccine tech into clinical trials this year, it is already focusing its attention on the techâs potential to be used as a needle-free booster shot to address Variants of Concern.

DNA 135

DNA Vaccine Vaccination Clinical Trials 135

Pharmaceutical Technology

APRIL 22, 2024

Detect cancer early with Eurofins' patented method analyzing cell-free DNA for methylated CpGs. Personalized treatment options outlined in recent patent.

DNA 130

DNA 130

Bio Pharma Dive

APRIL 18, 2024

Company head Anne Wojcicki is considering buying all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

DNA 263

DNA 263

pharmaphorum

JULY 12, 2024

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round

DNA 111

DNA Marketing 111

Bio Pharma Dive

SEPTEMBER 28, 2020

The FDA has suspended the planned start of a late-stage trial of Inovio's experimental shot, dealing another setback to one of the most advanced DNA-based vaccine programs in development.

Vaccine 279

Vaccine Vaccination DNA Trials 279

Bio Pharma Dive

OCTOBER 25, 2022

“Every struggle that I've had has woven a sense of persistence into my DNA,” said Zhang, in a wide-ranging interview about leading a biotech startup as a young CEO.

Genome 279

Genome Genomics DNA Drugs 279

Bio Pharma Dive

OCTOBER 12, 2022

The startup, run by Translate Bio cofounder Romesh Subramanian, believes its RNA “exon editing” approach could have long-lasting effects without the risks that come with editing DNA.

RNA 264

RNA DNA 264

Bio Pharma Dive

SEPTEMBER 12, 2022

Scientists at Pretzel believe fixing mutated mitochondrial DNA with a mix of small molecule therapies and gene editing could be key to solving a number of hard-to-treat diseases.

Gene Editing 264

Gene Editing DNA Gene Scientist 264

Pharmaceutical Technology

APRIL 30, 2024

Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.

Engineer 195

Engineer DNA Genetics Research 195

STAT News

SEPTEMBER 16, 2022

Intellia Therapeutics said Friday the first six patients to receive its CRISPR-based treatment for a genetic swelling disorder have safely had small, corrective changes made to dysfunctional DNA inside their liver cells.

DNA 142

DNA Gene Editing In-Vivo Genetics 142

Medical Xpress

NOVEMBER 17, 2022

BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instances, leading to breast and ovarian cancer, plays an important role in the body's DNA repair mechanisms. BRCA1, once mutated, can cause cancer to develop.

DNA 120

DNA Production Gene Development 120

Medical Xpress

DECEMBER 6, 2024

The Dawson lab at Peter Mac has developed a method that can take circulating tumor DNA (ctDNA) from the patient's blood and use an algorithm to identify cancer-related changes and patterns in their DNA.

DNA 86

DNA Scientist Development Research 86

pharmaphorum

SEPTEMBER 4, 2024

Swiss startup Haya Therapeutics has formed a $1bn partnership with Eli Lilly to look for new therapies for obesity in non-coding DNA

DNA 97

DNA Drugs 97

Fierce Pharma

JUNE 3, 2024

subsidiary Bionova Scientific is launching a new business line to provide services around plasmid DNA (pDNA), the companies announced Monday. As part of the pDNA pivot, Bionova is setting up a new facility in The Woodlands, Texas.

DNA 105

DNA Gene Therapy Contract Manufacturing Gene 105

STAT News

FEBRUARY 9, 2023

Or the baby girl who could have had a life-threatening reaction to anesthesia had researchers not sequenced her DNA ahead of time. They’ll tell you about the 3-month-old boy whose heart was failing until researchers pinpointed what was ailing him.

Genetic Disease 119

Genetic Disease DNA Genetics Genome 119

Medical Xpress

FEBRUARY 22, 2023

Mount Sinai researchers have published a study in Alzheimer's & Dementia: The Journal of the Alzheimer's Association that sheds new light on the role of DNA methylation in Alzheimer's disease (AD).

DNA 98

DNA Research Protein Gene 98

Medical Xpress

MAY 14, 2023

For two decades, scientists have been comparing every person's full set of DNA they study to a template that relies mostly on genetic material from one man affectionately known as "the guy from Buffalo."

DNA 98

DNA Scientist Genome Genomics 98

Fierce Pharma

JANUARY 4, 2023

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M. Wed, 01/04/2023 - 06:37.

DNA 105

DNA Manufacturing 105

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 30, 2024

Silently tucked away in our genomes, some of these bits of foreign DNA can get passed down through the generations. When viruses pay us a visit, they sometimes leave parts of themselves behind. They were long thought inactive, but we’ve since learned these stowaway sequences can be turned back on to wreak all sorts of […]

DNA 234

DNA Gene Genome Genomics 234